Daniela Gradinaru1, Denisa Margina2, Claudia Borsa3, Cristina Ionescu3, Mihaela Ilie2, Marieta Costache4, Anca Dinischiotu4, Gabriel-Ioan Prada3. 1. Department of Biochemistry, Faculty of Pharmacy, Carol Davila - University of Medicine and Pharmacy, 6 Taian Vuia street, sector 2, 020956, Bucharest, Romania. danielagrdnr@yahoo.com. 2. Department of Biochemistry, Faculty of Pharmacy, Carol Davila - University of Medicine and Pharmacy, 6 Taian Vuia street, sector 2, 020956, Bucharest, Romania. 3. Ana Aslan - National Institute of Gerontology and Geriatrics, 9 Caldarusani street, sector 1, PO Box 2-4, 011241, Bucharest, Romania. 4. Department of Biochemistry and Molecular Biology, Faculty of Biology, University of Bucharest, 91-95 Splaiul Independentei, sector 5, 050107, Bucharest, Romania.
Abstract
OBJECTIVE: The aim of this study was to evaluate the relationships between the serum levels of adiponectin and systemic oxidative stress exerted on lipids, proteins, as well as endothelial function and cardiovascular diseases (CVD) risk markers, in elderly subjects with metabolic syndrome (MS). METHODS: The serum advanced glycation and oxidation protein products, low-density lipoprotein susceptibility to oxidation (oxLDL), nitric oxide metabolic pathway products (NOx), serum lipid peroxidation, as well as total antioxidant/oxidative capacity (TAC/TOC), were analyzed in elderly subjects with MS (n = 44), compared to aged-matched control (n = 39). RESULTS: We pointed out significantly lower levels of adiponectin in elderly MS subjects concomitantly with significantly higher levels of oxidative stress and CVD risk markers. Significant positive correlations were found between serum adiponectin levels and HDL-cholesterol (p < 0.05) and the total cholesterol/LDL-cholesterol ratio (p < 0.01). Additionally, adiponectin levels were significantly inversely associated with insulin resistance index (HOMA-IR, r = -0.348; p < 0.05) and serum lipid peroxidation (r = -0.337; p < 0.05), and significantly positively with the antioxidant capacity (TAC, r = 0.339; p < 0.05). Conversely, adiponectin levels were significantly negatively (r = -0.310; p < 0.05) associated with serum uric acid concentration. CONCLUSIONS: The major protective role of adiponectin versus stress related to an impaired glucose and lipid metabolism suggests that adiponectin plays a critical role in adiposity-related metabolic stress and redox homeostasis.
OBJECTIVE: The aim of this study was to evaluate the relationships between the serum levels of adiponectin and systemic oxidative stress exerted on lipids, proteins, as well as endothelial function and cardiovascular diseases (CVD) risk markers, in elderly subjects with metabolic syndrome (MS). METHODS: The serum advanced glycation and oxidation protein products, low-density lipoprotein susceptibility to oxidation (oxLDL), nitric oxide metabolic pathway products (NOx), serum lipid peroxidation, as well as total antioxidant/oxidative capacity (TAC/TOC), were analyzed in elderly subjects with MS (n = 44), compared to aged-matched control (n = 39). RESULTS: We pointed out significantly lower levels of adiponectin in elderly MS subjects concomitantly with significantly higher levels of oxidative stress and CVD risk markers. Significant positive correlations were found between serum adiponectin levels and HDL-cholesterol (p < 0.05) and the total cholesterol/LDL-cholesterol ratio (p < 0.01). Additionally, adiponectin levels were significantly inversely associated with insulin resistance index (HOMA-IR, r = -0.348; p < 0.05) and serum lipid peroxidation (r = -0.337; p < 0.05), and significantly positively with the antioxidant capacity (TAC, r = 0.339; p < 0.05). Conversely, adiponectin levels were significantly negatively (r = -0.310; p < 0.05) associated with serum uric acid concentration. CONCLUSIONS: The major protective role of adiponectin versus stress related to an impaired glucose and lipid metabolism suggests that adiponectin plays a critical role in adiposity-related metabolic stress and redox homeostasis.
Authors: Denisa Margină; Anca Ungurianu; Carmen Purdel; George Mihai Nițulescu; Dimitris Tsoukalas; Evangelia Sarandi; Maria Thanasoula; Tatyana I Burykina; Fotis Tekos; Aleksandra Buha; Dragana Nikitovic; Demetrios Kouretas; Aristidis Michael Tsatsakis Journal: Food Chem Toxicol Date: 2020-07-05 Impact factor: 6.023
Authors: Dragos Paul Mihai; Anca Ungurianu; Cosmin I Ciotu; Michael J M Fischer; Octavian Tudorel Olaru; George Mihai Nitulescu; Corina Andrei; Cristina Elena Zbarcea; Anca Zanfirescu; Oana Cristina Seremet; Cornel Chirita; Simona Negres Journal: Int J Mol Sci Date: 2021-07-02 Impact factor: 5.923
Authors: Denisa Margină; Anca Ungurianu; Carmen Purdel; Dimitris Tsoukalas; Evangelia Sarandi; Maria Thanasoula; Fotios Tekos; Robin Mesnage; Demetrios Kouretas; Aristidis Tsatsakis Journal: Int J Environ Res Public Health Date: 2020-06-10 Impact factor: 3.390
Authors: Shuen Yee Lee; Stephen F Burns; Kenneth K C Ng; David J Stensel; Liang Zhong; Frankie H Y Tan; Kar Ling Chia; Kai Deng Fam; Margaret M C Yap; Kwee Poo Yeo; Eric P H Yap; Chin Leong Lim Journal: Antioxidants (Basel) Date: 2020-03-07